News

Biosenta announces that it has granted to certain directors, officers, employees and consultants of the Company 350,000 stock options.

Biosenta will enter into a series of prime plus 5% unsecured promissory notes in consideration for cash investments in the amount of $85,000

Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360.

Biosenta live on CTV News Ottawa in Ontario Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

Biosenta’s stock closed at 0.75 CAD +0.37 (97.37%). This is in step with Biosenta’s strategic business plan grow the company.

Biosenta live on CTV News Toronto in Ontario Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

Biosenta live on CTV News Barrie in Ontario Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

Biosenta live on CTV News Calgary in Alberta Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

A strategic licensing partnership with Kleen Bee Labs was finalized today. This license will give the rights for distribution of DualXtiv.

Biosenta is launching a dual-action, broad-spectrum anti-microbial disinfectant to combat COVID-19 in North America.